June B.

Madeira Beach, FL

June Shares Her Stem Cell Therapy Experience at the Lung Institute

Age: 67 | Location: Madeira Beach, FL | Condition: COPD

June was diagnosed with COPD in 2007. Although she managed the disease well until 2013, she was admitted to the hospital three times. During this time she lost her ability to walk, gained weight and saw her quality of life decreasing, which resulted in depression. After a friend told her she’d seen an interview about stem cell therapy from someone from the Lung Institute, June decided to call.

Noticing a difference within four weeks of treatment, steady improvement followed. June is now able to travel for work again and no longer needs the prescription medication she once couldn’t do without. Her daily three-mile walks have helped her lose 25 pounds, and she’s looking forward to taking line dancing classes with friends in Madeira Beach.

If you or a loved one has COPD or any other form of lung disease, and would like to see results like June, please contact one of our patient coordinators or call us at (800) 729-3065.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Jerry E.
Kernersville, NC
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Michael F.
Georgetown, TX
Susan B.
Edison, NJ
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.